Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 247

1.

Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis.

Patel P, Philip G, Yang W, Call R, Horak F, LaForce C, Gilles L, Garrett GC, Dass SB, Knorr BA, Reiss TF.

Ann Allergy Asthma Immunol. 2005 Dec;95(6):551-7.

PMID:
16400895
2.

Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring.

Philip G, Malmstrom K, Hampel FC, Weinstein SF, LaForce CF, Ratner PH, Malice MP, Reiss TF; Montelukast Spring Rhinitis Study Group.

Clin Exp Allergy. 2002 Jul;32(7):1020-8. Erratum in: Clin Exp Allergy. 2009 Oct;39(10):1622.

PMID:
12100048
3.

Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.

Meltzer EO, Malmstrom K, Lu S, Prenner BM, Wei LX, Weinstein SF, Wolfe JD, Reiss TF.

J Allergy Clin Immunol. 2000 May;105(5):917-22.

PMID:
10808172
4.

Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.

Nayak AS, Philip G, Lu S, Malice MP, Reiss TF; Montelukast Fall Rhinitis Investigator Group.

Ann Allergy Asthma Immunol. 2002 Jun;88(6):592-600.

PMID:
12086367
5.

Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.

Di Lorenzo G, Pacor ML, Pellitteri ME, Morici G, Di Gregoli A, Lo Bianco C, Ditta V, Martinelli N, Candore G, Mansueto P, Rini GB, Corrocher R, Caruso C.

Clin Exp Allergy. 2004 Feb;34(2):259-67. Erratum in: Clin Exp Allergy. 2004 Aug;34(8):1329.

PMID:
14987306
6.

Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.

van Adelsberg J, Philip G, LaForce CF, Weinstein SF, Menten J, Malice MP, Reiss TF; Montelukast Spring Rhinitis Investigator Group.

Ann Allergy Asthma Immunol. 2003 Feb;90(2):214-22.

PMID:
12602669
7.

The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis.

Philip G, Nayak AS, Berger WE, Leynadier F, Vrijens F, Dass SB, Reiss TF.

Curr Med Res Opin. 2004 Oct;20(10):1549-58.

PMID:
15462688
8.

Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.

Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL.

Pediatrics. 2001 Sep;108(3):E48.

PMID:
11533366
9.

Efficacy of montelukast for treating perennial allergic rhinitis.

Philip G, Williams-Herman D, Patel P, Weinstein SF, Alon A, Gilles L, Tozzi CA, Dass SB, Reiss TF.

Allergy Asthma Proc. 2007 May-Jun;28(3):296-304.

PMID:
17619558
10.

Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period.

van Adelsberg J, Philip G, Pedinoff AJ, Meltzer EO, Ratner PH, Menten J, Reiss TF; Montelukast Fall Rhinitis Study Group.

Allergy. 2003 Dec;58(12):1268-76. Erratum in: Allergy. 2004 Mar;59(3):357. Allergy. 2009 Nov;64(11):1697.

11.

Effects of montelukast on quality of life in patients with persistent allergic rhinitis.

Cingi C, Ozlugedik S.

Otolaryngol Head Neck Surg. 2010 May;142(5):654-8. doi: 10.1016/j.otohns.2010.01.016.

PMID:
20416451
12.

Montelukast in the treatment of allergic rhinitis: an evidence-based review.

Nayak A, Langdon RB.

Drugs. 2007;67(6):887-901. Review.

PMID:
17428106
13.

Clinical studies of combination montelukast and loratadine in patients with seasonal allergic rhinitis.

Lu S, Malice MP, Dass SB, Reiss TF.

J Asthma. 2009 Nov;46(9):878-83. doi: 10.3109/02770900903104540.

PMID:
19905912
14.

Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast.

Ratner PH, Howland WC 3rd, Arastu R, Philpot EE, Klein KC, Baidoo CA, Faris MA, Rickard KA.

Ann Allergy Asthma Immunol. 2003 May;90(5):536-42.

PMID:
12775135
15.

Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms.

Martin BG, Andrews CP, van Bavel JH, Hampel FC, Klein KC, Prillaman BA, Faris MA, Philpot EE.

Ann Allergy Asthma Immunol. 2006 Jun;96(6):851-7.

PMID:
16802774
16.

Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis.

Moinuddin R, deTineo M, Maleckar B, Naclerio RM, Baroody FM.

Ann Allergy Asthma Immunol. 2004 Jan;92(1):73-9.

PMID:
14756468
17.

Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis.

Mucha SM, deTineo M, Naclerio RM, Baroody FM.

Arch Otolaryngol Head Neck Surg. 2006 Feb;132(2):164-72.

PMID:
16490874
18.

Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies.

Chervinsky P, Philip G, Malice MP, Bardelas J, Nayak A, Marchal JL, van Adelsberg J, Bousquet J, Tozzi CA, Reiss TF.

Ann Allergy Asthma Immunol. 2004 Mar;92(3):367-73.

PMID:
15049402
19.

Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitis.

Esteitie R, deTineo M, Naclerio RM, Baroody FM.

Ann Allergy Asthma Immunol. 2010 Aug;105(2):155-61. doi: 10.1016/j.anai.2010.05.017. Epub 2010 Jun 19.

PMID:
20674827
20.

Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis.

Razi C, Bakirtas A, Harmanci K, Turktas I, Erbas D.

Ann Allergy Asthma Immunol. 2006 Dec;97(6):767-74.

PMID:
17201236

Supplemental Content

Support Center